| Date Filed | Type | Description |
| 08/16/2023 |
4
| Carter Eric G (Director) has filed a Form 4 on AEON Biopharma, Inc.|
Txns:
| Granted 58,851 options
@ $5.47, valued at
$321.9k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 45,000 options to buy
@ $13.41, valued at
$603.5k
|
|
| 06/15/2018 |
4
| Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 35,000 options to buy
@ $6.25, valued at
$218.8k
|
|
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2017 |
3
| Carter Eric G (Director) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 03/01/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 02/02/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 135,427 shares
@ $0
Disposed/sold 38,740 shares
@ $0
Disposed/sold 55,740 options to buy
@ $0
Disposed/sold 17,860 options to buy
@ $0
Disposed of 34,240 options to buy
@ $8.91, valued at
$305.1k
Disposed of 50,290 options to buy
@ $6.97, valued at
$350.5k
Disposed of 42,240 options to buy
@ $12.44, valued at
$525.5k
|
|
| 01/20/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2011 |
4/A
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,260 shares
@ $0
Granted 16,260 shares
@ $0 |
|
| 01/11/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,260 shares
@ $0 |
|
| 12/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,772 shares
@ $12.25, valued at
$21.7k
|
|
| 03/19/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 11,970 shares
@ $0
Granted 42,240 options to buy
@ $12.44, valued at
$525.5k
|
|
| 03/01/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 55,740 options to buy
@ $0 |
|
| 01/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Exercised 12,698 options to buy
@ $0 |
|
| 03/25/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/12/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 02/19/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/22/2009 |
4/A
| Form 4/A -- Statement of changes in beneficial ownership of securities [amend] |
| 01/21/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |